Labcorp Holdings Inc. logo

Labcorp Holdings Inc. (LH)

Market Closed
16 Oct, 08:00 PM
NYSE NYSE
$
317. 95
-7.12
-2.1903%
$
25.6B Market Cap
- P/E Ratio
2.47% Div Yield
706,000 Volume
- Eps
$ 325.07
Previous Close
Add Transaction
Day Range
316.12 327.5
Year Range
244.52 341.8
Want to track LH and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Why Labcorp Holdings (LH) is a Top Momentum Stock for the Long-Term

Why Labcorp Holdings (LH) is a Top Momentum Stock for the Long-Term

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Zacks | 1 year ago
Why Labcorp Holdings (LH) is a Top Growth Stock for the Long-Term

Why Labcorp Holdings (LH) is a Top Growth Stock for the Long-Term

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Zacks | 1 year ago
Here's Why Labcorp Holdings (LH) is a Strong Value Stock

Here's Why Labcorp Holdings (LH) is a Strong Value Stock

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Zacks | 1 year ago
Labcorp Holdings Inc. (LH) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript

Labcorp Holdings Inc. (LH) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript

Labcorp Holdings Inc. (NYSE:LH ) Morgan Stanley 23rd Annual Global Healthcare Conference September 9, 2025 7:45 AM EDT Company Participants Adam Schechter - President, CEO & Chairman Julia Wang - CFO & Executive VP Conference Call Participants Erin Wilson Wright - Morgan Stanley, Research Division Presentation Erin Wilson Wright Equity Analyst Good morning, everyone. I'm Erin Wright, health care services analyst at Morgan Stanley.

Seekingalpha | 1 year ago
Is it the Right Time to Hold Labcorp Stock in Your Portfolio?

Is it the Right Time to Hold Labcorp Stock in Your Portfolio?

LH witnesses growth in specialty testing and strategic acquisitions, but macro and currency headwinds remain a concern.

Zacks | 1 year ago
Here's Why Labcorp Holdings (LH) is a Strong Momentum Stock

Here's Why Labcorp Holdings (LH) is a Strong Momentum Stock

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Zacks | 1 year ago
Why Labcorp Holdings (LH) is a Top Growth Stock for the Long-Term

Why Labcorp Holdings (LH) is a Top Growth Stock for the Long-Term

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Zacks | 1 year ago
Labcorp Debuts First FDA-Cleared Blood Test for Alzheimer's, Stock Up

Labcorp Debuts First FDA-Cleared Blood Test for Alzheimer's, Stock Up

LH launches the first FDA-cleared blood test for Alzheimer's, boosting access to early diagnosis and nudging its stock higher.

Zacks | 1 year ago
Here's Why Labcorp Holdings (LH) is a Strong Value Stock

Here's Why Labcorp Holdings (LH) is a Strong Value Stock

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Zacks | 1 year ago
Why Labcorp Holdings (LH) is a Top Momentum Stock for the Long-Term

Why Labcorp Holdings (LH) is a Top Momentum Stock for the Long-Term

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Zacks | 1 year ago
Why Labcorp Holdings (LH) is a Top Value Stock for the Long-Term

Why Labcorp Holdings (LH) is a Top Value Stock for the Long-Term

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Zacks | 1 year ago
Labcorp Holdings Inc. (LH) Q2 2025 Earnings Call Transcript

Labcorp Holdings Inc. (LH) Q2 2025 Earnings Call Transcript

Labcorp Holdings Inc. (NYSE:LH ) Q2 2025 Earnings Conference Call July 24, 2025 9:00 AM ET Company Participants Adam H. Schechter - President, CEO & Chairman Christin O'Donnell - Vice President of Investor Relations Julia A.

Seekingalpha | 1 year ago
Loading...
Load More